High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial
Published Online: 2014-07-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: A John Ashcroft•Anna Chalmers•Cathy Williams•Chris Parrish•David A Cairns•Gordon Cook•Hanna Hunter•Jamie Cavenagh•Jenny M Bird•Jim Cavet•John A Snowden•Julia M Brown•Kwee Yong•Marie Fletcher•Mark T Drayson•Sheila O'Connor•Treen C M Morris
